Advertisement
News
Subscribe to MDT Magazine News

Ky. hands over its lethal injection drug to DEA

April 1, 2011 9:45 am | by The Associated Press | Comments

Kentucky has turned over its supply of a key lethal injection drug to the federal Drug Enforcement Administration, officials said Friday.Kentucky Justice Department spokeswoman Jennifer Brislin said in a statement that the state turned over its supply of sodium thiopental to be used as evidence...

Breast health global initiative offers unprecedented tools for developing nations

April 1, 2011 9:38 am | by EurekAlert | Comments

(Fred Hutchinson Cancer Research Center) A landmark breast health care publication reveals a multitude of barriers that keep women of developing nations from being screened and treated for breast cancer -- but offers tools to help countries improve their breast care programs.

TOPICS:

Boehringer Ingelheim lands good news on HCV treatment

April 1, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Boehringer Ingelheim Corp., a pharmaceutical firm in Ridgefield, Conn., has returned positive antiviral activity results from a Phase 2 clinical trial of its hepatitis C virus (HCV) treatment, BI 201335.

Advertisement

Online Forum for Accountable Care Organization Developments Launches Today; Squire Sanders Sponsorship Reflects Commitment to Leadership in Emerging Health Policy Debate

April 1, 2011 9:36 am | by Bio-Medicine.Org | Comments

WASHINGTON, April 1, 2011 /- Squire, Sanders & Dempsey is launching Accountable Care Forum - From Volume to Value , a blog dedicated to analysis of the emerging accountable care organization (ACO) landscape. The launch coincides with regulations issued today by the Centers for...

TOPICS:

Lance® Joins JDRF in the Fight Against Type 1 Diabetes

April 1, 2011 8:36 am | by Bio-Medicine.Org | Comments

CHARLOTTE, N.C., April 1, 2011 /PRNewswire-USNewswire/ -- Lance® Sandwich Crackers is partnering with the Juvenile Diabetes Research Foundation (JDRF) to support the organization's efforts to find better treatments and a cure for type 1 diabetes. Type 1 diabetes is an autoimmune...

TOPICS:

Milestone Scientific Will Host Its 2011 Conference Call on Monday, April 4, 2011

April 1, 2011 8:35 am | by Bio-Medicine.Org | Comments

LIVINGSTON, N.J., April 1, 2011 /- Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced computer-controlled technologies, today announced that the Company filed its 2010 year-end results for the 12 months ended December 31, 2010 with the U.S. Securities &...

TOPICS:

"IVD Technology" Announces Upcoming Webcast: Omics and the Development of IVDs

April 1, 2011 8:32 am | by Bio-Medicine.Org | Comments

LOS ANGELES, April 1, 2011 /- UBM Canon and IVD Technology today announced an upcoming webinar in its webcast series on The Fundamentals of In Vitro Diagnostics. This one-hour event will focus specifically on Omics and the Development of IVDs and will offer an in-depth analysis and...

TOPICS:

Western Massachusetts: the next life sciences hub?

April 1, 2011 7:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Smith College in Northampton held a forum – featuring Susan Windham-Bannister of the Massachusetts Life Sciences Center, Allan W. Blair of the Economic Development Council of western Massachusetts, and Abigail Barrow of Massachusetts Technology Transfer Center – aimed at recreating the...

Advertisement

PositiveID Corporation to Host WebEx of Its iglucose Diabetes Management Wireless Solution for Interested Licensees, Physicians, Patients and Investors

April 1, 2011 7:33 am | by PositiveID | Comments

PositiveID Corporation to Host WebEx of Its iglucose Diabetes Management Wireless Solution for Interested Licensees, Physicians, Patients and Investors

TOPICS:

NeoStem Provides Results for 2010 and an Update on Recent Activities

April 1, 2011 6:37 am | by Bio-Medicine.Org | Comments

NEW YORK, April 1, 2011 /- NeoStem, Inc. (NYSE Amex: NBS ) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, is today providing unaudited results for 2010 and an update of recent activities: Revenues for the year ended December...

TOPICS:

Positive Phase 2 Results Reported with Boehringer Ingelheim's Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients

April 1, 2011 6:37 am | by Bio-Medicine.Org | Comments

BERLIN and RIDGEFIELD, Conn., April 1, 2011 /- New data presented today at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL) demonstrate the antiviral activity of Boehringer Ingelheim's once-daily oral protease inhibitor, BI 201335, in both...

TOPICS:

Select Data Delivers on the Promise of a True Electronic Medical Record

April 1, 2011 6:37 am | by Bio-Medicine.Org | Comments

ANAHEIM, Calif., April 1, 2011 /- Select Data ( www.selectdata.com ) has achieved the task of creating a true electronic medical record that not only meets the meaningful use guidelines set forth by the Affordable Care Act (ACA) while exceeding those requirements through the use of a...

TOPICS:

Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011

April 1, 2011 5:37 am | by Bio-Medicine.Org | Comments

GREENWOOD VILLAGE, Colo., April 1, 2011 /- Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE ) ("Ampio") announced today that Mark D. McGregor will be appointed to the position of Chief Financial Officer and Corporate Secretary effective April 4, 2011. Mr. Bruce G. Miller, who served...

TOPICS:

CarePoint Partners Kicks Off Food Drive to Help Fight Hunger in Twenty-One Local Communities

April 1, 2011 5:37 am | by Bio-Medicine.Org | Comments

CINCINNATI, April 1, 2011 /- CarePoint Partners, one of the largest, fastest growing independent home infusion therapy companies in the United States, launched a food drive today throughout its twenty-one locations in eight states to help the less fortunate in the communities where it...

TOPICS:

ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2010

April 1, 2011 5:37 am | by Bio-Medicine.Org | Comments

ADDISON, Texas, April 1, 2011 /- ULURU Inc. (NYSE AMEX: ULU) today announced its financial results for the fourth quarter and year ended December 31, 2010.   For the fourth quarter of 2010, the Company reported a net loss of $0.3 million, or $0.004 per share, compared with a net loss...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading